202 related articles for article (PubMed ID: 32188801)
21. Effects of pimobendan on left atrial transport function in cats.
Kochie SL; Schober KE; Rhinehart J; Winter RL; Bonagura JD; Showers A; Yildez V
J Vet Intern Med; 2021 Jan; 35(1):10-21. PubMed ID: 33241877
[TBL] [Abstract][Full Text] [Related]
22. Bradyarrhythmia after treatment with atenolol and mirtazapine in a cat with hypertrophic cardiomyopathy.
Oricco S; Quintavalla C; Apolloni I; Crosara S
J Vet Cardiol; 2024 Jun; 53():72-76. PubMed ID: 38735230
[TBL] [Abstract][Full Text] [Related]
23. Incremental value of left atrial active function measured by speckle tracking echocardiography in patients with hypertrophic cardiomyopathy.
Fujimoto K; Inoue K; Saito M; Higashi H; Kono T; Uetani T; Aono J; Nagai T; Nishimura K; Suzuki J; Okura T; Ikeda S; Nakatani S; Higaki J
Echocardiography; 2018 Aug; 35(8):1138-1148. PubMed ID: 29648690
[TBL] [Abstract][Full Text] [Related]
24. Assessment of diastolic function using mitral flow propagation velocity in cats.
Sugimoto K; Kawase N; Aoki T
Can J Vet Res; 2020 Apr; 84(2):124-130. PubMed ID: 32255907
[TBL] [Abstract][Full Text] [Related]
25. Effect of pimobendan on left atrial function: an echocardiographic pilot study in 11 healthy cats.
Baron Toaldo M; Pollesel M; Diana A
J Vet Cardiol; 2020 Apr; 28():37-47. PubMed ID: 32244178
[TBL] [Abstract][Full Text] [Related]
26. Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation.
Tian H; Cui J; Yang C; Hu F; Yuan J; Liu S; Yang W; Jiang X; Qiao S
BMC Cardiovasc Disord; 2018 Nov; 18(1):207. PubMed ID: 30390664
[TBL] [Abstract][Full Text] [Related]
27. Right ventricular involvement in feline hypertrophic cardiomyopathy.
Schober KE; Savino SI; Yildiz V
J Vet Cardiol; 2016 Dec; 18(4):297-309. PubMed ID: 27667689
[TBL] [Abstract][Full Text] [Related]
28. Left ventricular geometric characteristics predict response to carvedilol in cats with asymptomatic hypertrophic obstructive cardiomyopathy caused by systolic anterior motion of the mitral valve.
Mochizuki Y; Suzuki R; Yasumura Y; Saito T; Teshima T; Matsumoto H; Koyama H
J Vet Med Sci; 2019 May; 81(5):734-738. PubMed ID: 30944272
[TBL] [Abstract][Full Text] [Related]
29. Antioxidant defence and oxidative stress markers in cats with asymptomatic and symptomatic hypertrophic cardiomyopathy: a pilot study.
Michałek M; Tabiś A; Pasławska U; Noszczyk-Nowak A
BMC Vet Res; 2020 Jan; 16(1):26. PubMed ID: 32000761
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the effects of ivabradine and atenolol on heart rate and echocardiographic variables of left heart function in healthy cats.
Riesen SC; Schober KE; Cervenec RM; Bonagura JD
J Vet Intern Med; 2011; 25(3):469-76. PubMed ID: 21418320
[TBL] [Abstract][Full Text] [Related]
31. Left Atrial Mechanical Function and Global Strain in Hypertrophic Cardiomyopathy.
Kim KJ; Choi HM; Yoon YE; Kim HL; Lee SP; Kim HK; Kim YJ; Cho GY; Zo JH; Sohn DW
PLoS One; 2016; 11(6):e0157433. PubMed ID: 27336444
[TBL] [Abstract][Full Text] [Related]
32. Echocardiographic Assessment of Right Ventricular Size and Function in Cats With Hypertrophic Cardiomyopathy.
Visser LC; Sloan CQ; Stern JA
J Vet Intern Med; 2017 May; 31(3):668-677. PubMed ID: 28295648
[TBL] [Abstract][Full Text] [Related]
33. Pulsed Doppler assessment of left ventricular diastolic function in normal and cardiomyopathic cats.
Bright JM; Herrtage ME; Schneider JF
J Am Anim Hosp Assoc; 1999; 35(4):285-91. PubMed ID: 10416771
[TBL] [Abstract][Full Text] [Related]
34. Hypertrophic cardiomyopathy in pediatric patients: effect of verapamil on regional and global left ventricular diastolic function.
Pacileo G; De Cristofaro M; Russo MG; Sarubbi B; Pisacane C; Calabrò R
Can J Cardiol; 2000 Feb; 16(2):146-52. PubMed ID: 10694584
[TBL] [Abstract][Full Text] [Related]
35. Characterization of Left Atrial Mechanics in Hypertrophic Cardiomyopathy and Essential Hypertension Using Vector Velocity Imaging.
Badran HM; Faheem N; Elnoamany MF; Kenawy A; Yacoub M
Echocardiography; 2015 Oct; 32(10):1527-38. PubMed ID: 25600773
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of coagulation markers in the plasma of healthy cats and cats with asymptomatic hypertrophic cardiomyopathy.
Bédard C; Lanevschi-Pietersma A; Dunn M
Vet Clin Pathol; 2007 Jun; 36(2):167-72. PubMed ID: 17523090
[TBL] [Abstract][Full Text] [Related]
37. The Feline Cardiomyopathies: 3. Cardiomyopathies other than HCM.
Kittleson MD; Côté E
J Feline Med Surg; 2021 Nov; 23(11):1053-1067. PubMed ID: 34693805
[TBL] [Abstract][Full Text] [Related]
38. Myocardial collagen deposition and inflammatory cell infiltration in cats with pre-clinical hypertrophic cardiomyopathy.
Khor KH; Campbell FE; Owen H; Shiels IA; Mills PC
Vet J; 2015 Feb; 203(2):161-8. PubMed ID: 25573453
[TBL] [Abstract][Full Text] [Related]
39. End-stage hypertrophic cardiomyopathy in a cat.
White AJ
Can Vet J; 2015 May; 56(5):509-11. PubMed ID: 25969586
[TBL] [Abstract][Full Text] [Related]
40. Tissue Doppler imaging and gradient echo cardiac magnetic resonance imaging in normal cats and cats with hypertrophic cardiomyopathy.
MacDonald KA; Kittleson MD; Garcia-Nolen T; Larson RF; Wisner ER
J Vet Intern Med; 2006; 20(3):627-34. PubMed ID: 16734100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
